Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6099863 | JANSSEN PHARMS | Fast-dissolving galanthamine hydrobromide tablet |
Jun, 2017
(6 years ago) | |
US6358527 | JANSSEN PHARMS | Fast-dissolving galanthamine hydrobromide tablet |
Jun, 2017
(6 years ago) |
Market Authorisation Date: 28 February, 2001
Treatment: Treatment of alzheimer's dementia
Dosage: TABLET;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7160559 | JANSSEN PHARMS | Controlled release galantamine composition |
Dec, 2019
(4 years ago) |
Market Authorisation Date: 01 April, 2005
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL